about
Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus InfectionGlobulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.Changes of FibroScan, APRI, and FIB-4 in chronic hepatitis B patients with significant liver histological changes receiving 3-year entecavir therapy.A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminaseNoninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infection
P50
description
researcher (ORCID 0000-0003-3831-9001)
@en
name
Qiang Li
@en
type
label
Qiang Li
@en
prefLabel
Qiang Li
@en
P31
P496
0000-0003-3831-9001